The following article was featured in:
Source:
Dallas Health Care RSS Feed
1/11/2022.
Biopharmaceutical company ReCode Therapeutics announced today the appointment of Dr. Shehnaaz Suliman as chief executive officer and member of the board. She replaces David Lockhart, who will...
Continue on to full article...
